Live Webinar

Protein expression remains a critical bottleneck in the journey of biotherapeutic development, spanning from initial discovery to lead optimization and beyond. The prolonged timelines associated with cell-line development exacerbate this challenge, necessitating the exploration of novel technologies for expediting the process.

In this 30-minute webinar, LenioBio’s Chief Scientific Officer, Dr. Ricarda Finnern, will delve into the transformative potential of a next generation cell-free protein expression platform in overcoming these hurdles. Through case studies, attendees will gain a comprehensive understanding of how this innovative system accelerates the development of vaccines and biotherapeutics, including detailed insights into a rapid high-throughput screening protocol. Ricarda will also share first in-animal pharmacokinetics data obtained with a therapeutic antibody, offering valuable insights into the quality and safety profile of proteins produced using the platform.

Join us as we embark on a journey to revolutionize biotherapeutic development, leveraging cutting-edge technology to overcome traditional limitations and expedite the translation of scientific discoveries into tangible medical solutions.